A Precautionary Tale: District Courts Take Varying Measures As In-Person Trials Appear on the Horizon
While the strain of the pandemic and its attendant restrictions are universally being felt within the court system, not all jurisdictions are alike when it comes to the precautions deemed necessary to proceed cautiously with in-person trials.
Many of Us Will Be Working From Home Forever
Elizabeth Dornburgh was quoted by Insider Pro on working remotely during the pandemic.
COVID Prompts Compromise: Jury Trial Set to Proceed In-Person Partially
Courts are grappling with the question of when to resume jury trials and how to keep the litigants, attorneys, witnesses, jurors and court staff safe once they do.
Remote Depositions During COVID-19 and Beyond
While remote depositions are not a new aspect of litigators’ practice, the COVID-19 pandemic has forced many to adopt this previously underutilized aspect of discovery proceedings.
The Impact of Foreign-Based Witnesses on COVID-Related Requests for Extensions
Recent orders in the Eastern District of Texas demonstrate the potential impact of foreign discovery during the pandemic.
COVID-19: Impact on Patent Procedures
The impact COVID-19 has had on patent procedures. Topics covered include impact on United States practice, impact on European practice, other jurisdictions and takeaways.
COVID-19 Prioritized Examination Pilot Program
The USPTO announced a new program designed to prioritize examination of patents geared towards the prevention or treatment of COVID-19.
Hearings in the Time of COVID-19: Effective Representation While Remote
Effectively all hearings and oral arguments must be cancelled, rescheduled or conducted remotely. Here are insights gleaned from remote hearings.
American Bar Association’s Legal Rebels Podcast
John Van Amsterdam was featured on the ABA’s Legal Rebels Podcast to discuss virtual hiring and onboarding during COVID-19 as well as ways in which he’s connecting with clients.
IP Litigation Timing Considerations in Light of COVID-19
Parties to pending or future IP litigation should consider the effects of COVID-19 related restrictions and measures when developing a strategy for moving cases forward.
How Five IP Lawyers Adapted to New Jobs During COVID
Tonia Sayour was quoted by Managing IP on adapting to a new job during COVID.
One Size Does Not Fit All:
Courts Exercise Discretion in Addressing the Need for Remote Depositions in the Wake of COVID-19
Courts across the country are responding by modifying their standard procedures.
Pandemic Collaborations Pose Risk Of Future Patent Disputes
Dan Young was quoted by Law360 on the importance of taking a step back to make sure key IP issues are being addressed when forming COVID-19 collaborations.
Must the Show Go On? Some Judges Press Forward Scheduling Remote Patent Bench Trials
Two recent decisions indicate the judiciary’s willingness and desire to move patent cases along.
Appearing Before PTAB During COVID-19: What You Need to Know
Important changes practitioners should know regarding case management, CARES Act extensions and remote hearings at the PTAB.
Serving Notice While Six Feet Apart: Substituted Service in Light of COVID-19
This article explains what litigants on both sides of the “v.” need to know about service during the pandemic.
What Civil Jury Trials Might Look Like In The Time of COVID
While all jury trials for civil cases are currently still on hold in the District of Massachusetts, learn what civil jury trials may look like when they are eventually conducted.
Lawyers Ponder Impact of COVID Cocktail Lawsuit
Chelsea Loughran was quoted by Managing IP on the impact of COVID-related patent lawsuits.
Impact and 'Unintended Benefits' of the Federal Circuit's Suspension of In-Person Oral Arguments
This article on the Federal Circuit by Greg Corbett and Marie McKiernan was published in Law.com.
COVID-19 Changes How Some Courts Consider Motions to Stay Pending IPR
In some instances, courts shifting resources to address COVID-19-related concerns is changing how courts evaluate motions to stay pending IPR.
IP Deadline Extensions Across The Globe Due to COVID-19
In this alert, we present a snapshot summary of actions taken by various IP offices with respect to extensions of deadlines and payment of fees due COVID-19.
WIPO Launches COVID-19 IP Policy Tracker
The World Intellectual Property Organization has launched the COVID-19 IP Policy Tracker, a tool that provides information on pandemic-related intellectual property office policy changes.
The Open COVID Pledge: What You Need to Know
Some organizations and institutions are pledging to make their intellectual property freely available to end the COVID-19 pandemic. This article discusses "The Open COVID Pledge."
Amgen and the Amgen Foundation have committed up to $12.5 million to support COVID-19 relief efforts.
The Analog Devices Foundation donated $500,000 to Massachusetts General Hospital’s Vaccine & Immunotherapy Center to advance COVID-19 vaccine development.
Beckton Dickinson is seeking emergency US approval to ramp up coronavirus tests.
BioAegis is developing rhu-pGSN (recombinant human plasma gelsolin) based on a patent portfolio licensed from The Brigham and Women’s Hospital.
Boehringer Ingelheim donated $1 million in goods to the China Red Cross Foundation and is investigating antiviral compounds from past research against SARS-CoV2.
Grocery delivery startup Boxed sees soaring demand amid pandemic. The company is prioritizing first responders’ orders.
The Broad Institute is contributing to Massachusetts’s COVID-19 diagnostic testing, developing new diagnostic technologies and data analysis tools, and generating new biological insights.
Butterfly Network’s portable ultrasound can image lungs or hearts hurt from coronavirus and hopes to lessen the stress on the health care system.
Comrad has donated over $30,000 worth of compression socks to nurses and doctors at the front line and they are accepting donations to provide more.
Dana-Farber Cancer Institute began running low on critical PPE and researchers found a solution.
Dean Kamen of DEKA helped secure a shipment of protective equipment from China for New Hampshire.
FLIR Systems was quoted in an article about how thermal imaging cameras are the latest devices businesses hope will help reopen the economy.
Formlabs, University of South Florida Health, Northwell Health and Tampa General Hospital joined forces to create 3D printed nasal swabs to test for COVID-19 in patients in emergency shortage situations.
In addition, the FDA granted Formlabs emergency clearance for 3D-printed ventilator component.
Ginkgo commits $25 million of free access to platform for partner COVID-19 projects.
GreenLight Biosciences is expanding their vaccine efforts to establish a scalable current Good Manufacturing Practices (cGMP) manufacturing platform to allow for the production of almost any RNA-based COVID-19 vaccine at a scale and cost that enables global delivery. In addition, they are advancing a number of RNA-based vaccines and therapeutics against COVID-19.
Judy, an in-case-of-emergency kit startup that is promising to be “ready for anything,” is working with experts to create curated disaster boxes based on where people live.
Eli Lilly and Co. reached an agreement with the National Institutes of Health to study one of its drugs as a COVID-19 treatment. The drug is approved in more than 65 countries as a treatment for adults with moderately to severely active rheumatoid arthritis.
They also opened labs and planned drive-thrus to help boost Indiana's COVID-19 testing capacity.
Kaleido Biosciences has initiated a controlled clinical study of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19.
Since then, Kaleido Biosciences has initiated a controlled clinical study with Mass General Hospital of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19.
A group at MIT figured out how to make an emergency ventilator for $100 using a common hospital item—instead of the usual $30,000.
After starting human trials for a COVID-19 vaccine, Moderna was featured on 60 minutes.
Since then, their potential coronavirus vaccine got $483 million boost from Feds.
Moderna announced positive interim Phase 1 data for its mRNA vaccine (mRNA-1273) against novel coronavirus.
Moderna, the first company to start US clinical trials of a Covid-19 vaccine, finished enrolling all 30,000 of its participants.
Early data shows Moderna's coronavirus vaccine is 94.5% effective.
Moderna intends to apply to the US Food and Drug Administration for authorization of its Covid-19 vaccine.
NOBULL is donating thousands of CDC recommended face masks to medical professionals. They were able to access the masks from an FDA registered factory through their partners. They are accepting donations to procure face masks or other PPE for medical professionals.
Nuance Communications announced the Nuance Dragon Ambient eXperience solution for telehealth providers.
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the Centers for Disease Control and Prevention (CDC).
Position
Pluristem Therapeutics Inc. (PSTI) announced it has treated its first patient suffering from COVID-19 under the FDA Single Patient Expanded Access Program.
Pfizer and BioNTech are co-developing a potential COVID-19 vaccine.
Pfizer and the Pfizer Foundation have also announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the US and around the world.
Researchers across the globe are deploying Quanterix Corporation’s Simoa® technology to profile innate immune response in COVID-19 patients, with the aim of identifying indicators associated with poor outcomes and opening new avenues for targeted therapies.
Translate Bio and Sanofi Pasteur are collaborating to develop a novel mRNA vaccine candidate against COVID-19.
